The ICEMVO annual flat fee is charged per market authorization holder to cover, inter alia, the annual costs of the operation and further development of the ICEMVS, costs inherited from the European Medicines Verification Organization and all necessary and legally compulsory activities of the ICEMVO. The level of the annual flat fee contribution will be based on actual cost of running the ICEMVO short and long term.
The amount of the yearly flat fee (IT-cost and operational cost of ICEMVO divided by number of MAH’s) may fluctuate from time to time.
ICEMVO 2019 Annual Fee has been decided by ICEMVO Board of Directors. It will be EUR 4.900 for MAH with IDM sales turnover above 10 m ISK (80k EUR) and EUR 1.500 for MAH with IDM sales turnover below 10 m ISK (80k EUR).
For any further information please contact ICEMVO via email email@example.com